Morgan Stanley MS · NYSE
$186.98 +1.90% (+$3.49)
Summary
76 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 18% a year over the last 3 years.
- It has raised its dividend 12 years in a row and pays out only 37% of profit.
- Out of every 100 USD of revenue, 17 USD is left as net profit.
What to watch
- The share price is above the Bulios Fair Price.
- Analysts expect revenue to fall by 28% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 16.7 USD for 1 USD of yearly profit. Over the last five years it was 14.8 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 18% a year over 5 years. Over the last 3 years it grew by 23% a year. For the next fiscal year analysts expect revenue to fall by 28%. Earnings per share grew by 18% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 36 USD
- Sales and administration 36 USD
- Taxes and other 2.3 USD
- Net profit 17 USD
Net profit, industry median (Financial - Capital Markets) 21 USD
Out of every 100 USD of revenue, 17 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 2.22%
- Paid out of profit
- 37%
- Raised in a row
- 12 years
You receive $4.15 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 29
- Hold 23
- Sell 1
Today's price within the analysts' price targets
The average target of $229.25 is 23% above today's price. 55% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Institutional Securities Segment 46%
- Wealth Management Segment 44%
- Investment Management Segment 9.1%
By region
- Americas 75%
- Asia 13%
- EMEA 12%
Institutional Securities Segment brings in 46% of revenue. Wealth Management Segment grew fastest, by 7.0% a year.
Segments in detail